SEMA3A levels have been reported to be significantly elevated in the vitreous fluid of patients with diabetic macular edema (33) and proliferative diabetic retinopathy (PDR) (34) via NRP1. The gene discussed is SEMA3A; the disease is proliferative diabetic retinopathy.